Magaldrate

Magaldrate
Magaldrate
Systematic (IUPAC) name
Magnesium aluminate monohydrate
Clinical data
AHFS/Drugs.com Micromedex Detailed Consumer Information
MedlinePlus a682683
Pregnancy cat. C
Legal status OTC
Routes Oral
Pharmacokinetic data
Bioavailability Negligible
Metabolism Nil
Excretion Fecal and renal
Identifiers
CAS number 1317-26-6
ATC code A02AD02 A02AF01
PubChem CID 6336542
ChemSpider 4891688 YesY
UNII 6V88E24N5T YesY
Chemical data
Formula AlMg2(OH)7·H2O
Mol. mass 212.66 g/mol
 YesY(what is this?)  (verify)

Magaldrate (INN), is a common antacid drug that is used for the treatment of duodenal and gastric ulcers, esophagitis from gastroesophageal reflux.

Contents

Available forms

Magaldrate is available in the form of oral suspension or tablets.

Interactions and adverse reactions

Magaldrate may negatively influence drugs like tetracyclines, benzodiazepines, and indomethacin. High doses or prolonged usage may lead to an increment of defecation and a reduction in feces consistence. In some cases it can alter the functionality of the gastrointestinal tract, occasionally provoking constipation or diarrhea.

Brand names

The drug is sold with the following brand names: Gadral (Italy); Magaltop (Italy); Magralibi (Italy); Mylanta (Australia); Riopan (Argentina, Austria, Brazil, Germany, Italy, Mexico, Belgium, Switzerland, Greece).

References

v · d · eDrugs for acid related disorders: Antacids (A02A) →
Magnesium
(increases motility)
Aluminium
(decreases motility)
Calcium
Sodium
Combinations and complexes
of aluminium, calcium and magnesium
Almagate • Almasilate • Hydrotalcite • Magaldrate

M: DIG

anat(t, g, p)/phys/devp/enzy

noco/cong/tumr, sysi/epon

proc, drug(A2A/2B/3/4/5/6/7/14/16), blte


Stub icon This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.